Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Lung Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00058006
What this trial is testing

Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer

Who this might be right for
Head and Neck CancerLung Cancer
Northwestern University
Not applicableStudy completedNCT02408406
What this trial is testing

PatientCareAnywhere Internet-Based Software in Improving Communication and Education in Patients With Cancer and Their Healthcare Providers

Who this might be right for
Bladder CarcinomaBreast CarcinomaColorectal Carcinoma+3 more
City of Hope Medical Center 140
Testing effectiveness (Phase 2)Looking for participantsNCT06047379
What this trial is testing

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Who this might be right for
Diffuse Astrocytoma, IDH-MutantGlioblastoma, IDH-wildtypeBrain Metastases, Adult+18 more
Neonc Technologies, Inc. 134
Testing effectiveness (Phase 2)Active Not RecruitingNCT05585320
What this trial is testing

A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorPancreatic AdenocarcinomaMalignant Melanoma (Cutaneous)+1 more
Immuneering Corporation 209
Not applicableLooking for participantsNCT05463796
What this trial is testing

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Who this might be right for
Cancer RiskCancer Predisposition SyndromeHereditary Cancer Prediction+28 more
Dana-Farber Cancer Institute 5,000
Not applicableLooking for participantsNCT05022446
What this trial is testing

The Impact of COVID-19 on Pulmonary Procedures

Who this might be right for
COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 250
Testing effectiveness (Phase 2)WithdrawnNCT03868423
What this trial is testing

Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Cancers

Who this might be right for
Advanced Malignant NeoplasmALK Fusion Protein ExpressionALK Gene Amplification+8 more
Sameek Roychowdhury
Not applicableUnknownNCT05465759
What this trial is testing

Frequency of SARS COVID-19 Infection Among Malignant Patients at South Egypt Cancer Institute

Who this might be right for
COVID-19
Assiut University 200
Early research (Phase 1)Ended earlyNCT06376253
What this trial is testing

A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers

Who this might be right for
Ovarian CancerLung Cancer
Novartis Pharmaceuticals 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT02971501
What this trial is testing

Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainStage IV Lung Cancer AJCC v8
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)UnknownNCT05930665
What this trial is testing

Study of Cadonilimab Combined With Bevacizumab and Standard Chemotherapy as First Line Therapy in Unresectable Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma
Sun Yat-sen University 38
Not applicableStudy completedNCT02378337
What this trial is testing

Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality

Who this might be right for
Malignant Neoplasm of BreastHodgkin DiseaseNon-Hodgkin Lymphoma, Follicular (Nodular)+5 more
Hospital Sao Rafael 335
Testing effectiveness (Phase 2)Study completedNCT00215930
What this trial is testing

The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
H. Lee Moffitt Cancer Center and Research Institute 53
Not applicableUnknownNCT04730453
What this trial is testing

ENB-guided Ablation Therapy Combined With VATS in the Treatment of MPLC

Who this might be right for
Lung Cancer
Shanghai Chest Hospital 30
Not applicableActive Not RecruitingNCT04314401
What this trial is testing

National Cancer Institute "Cancer Moonshot Biobank"

Who this might be right for
Acute Myeloid LeukemiaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+26 more
National Cancer Institute (NCI) 1,600
Very early researchStudy completedNCT03755102
What this trial is testing

A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers With Disease Progression on Osimertinib.

Who this might be right for
EGFR Gene MutationLung CancerLung Cancer Metastatic
Memorial Sloan Kettering Cancer Center 17
Not applicableUnknownNCT01619241
What this trial is testing

Pilot Study for Evaluating the Role of F-18 FLT PET/CT in Therapeutic Decision Making in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
The Catholic University of Korea 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06809946
What this trial is testing

Feasibility of Fluorescence Imaging With Bevacizumab-800CW During Bronchoscopy

Who this might be right for
Lung NeoplasmsPulmonary NeoplasmsLymph Node Involvement+1 more
University Medical Center Groningen 20
Early research (Phase 1)Study completedNCT01579994
What this trial is testing

Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers

Who this might be right for
Advanced Lung Cancer
Memorial Sloan Kettering Cancer Center 13
Early research (Phase 1)Active Not RecruitingNCT02589522
What this trial is testing

Testing the Safety of M6620 (VX-970) When Given With Standard Whole Brain Radiation Therapy for the Treatment of Brain Metastases From Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Neuroendocrine Tumors

Who this might be right for
Metastatic Lung Neuroendocrine NeoplasmMetastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+4 more
National Cancer Institute (NCI) 15
Next Page